• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Cluster analysis identifies phenotype groups for atrial fibrillation with unique clinical outcomes

byJames EnglandandAnees Daud
November 21, 2017
in Cardiology, Chronic Disease, Emergency, Imaging and Intervention, Neurology, Public Health, Surgery
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Cluster analysis of a population of patients with atrial fibrillation (AF) identified four unique phenotypes using variables not traditionally associated with AF classification.

2. The four phenotypic AF groups were associated with differences in treatment strategies and clinical outcomes.

Evidence Rating Level: 3 (Average)    

Study Rundown: Atrial fibrillation is the most common cardiac arrhythmia and is associated with significant morbidity. Traditional classification systems have characterized patients based on duration or thromboembolic risk. The current classification systems may not capture the full extent of diversity of AF patients and could fail to encapsulate important variables for disease course. The current study sought to re-evaluate clinical phenotypes of AF by evaluating a study population with cluster variable analysis and determine the connection between phenotype and treatment and clinical outcomes. The analysis determined four phenotypic groupings: a low comorbidity group, young patients with comorbid behavioral disorders, patients requiring device implantation, and those with atherosclerotic disease comorbidities. The study found adverse cardiovascular and neurologic events were more common amongst the 3-comorbidity groups, and major bleeding was more common in the behavioral comorbidity, and device implantation groups.

The study has important significance as it applies a novel statistical approach to describe phenotypic groups of patients with AF which may prove more meaningful that current classification systems. Factors that comprise the current classification of AF were not determined to be significant in the cluster analysis. The study has a large population and was also externally validated in a second large population. The main limitations of the study include the reliance on a set number of available variables, and the influence of existing patterns of care on clinical outcomes.

Click to read the study in JAMA Cardiology

Relevant Reading: Clinical Classifications of Atrial Fibrillation Poorly Reflect Its Temporal Persistence: Insights From 1,195 Patients Continuously Monitored With Implantable Devices

RELATED REPORTS

Reduced bleeding risk with asundexian compared to apixaban in patients with atrial fibrillation

Rivaroxaban associated with significantly increased risk of major ischemic or hemorrhagic events versus apixaban in patients with atrial fibrillation

#VisualAbstract: Pericardiotomy after cardiac surgery may reduce the incidence of postoperative atrial fibrillation

In-Depth [prospective cohort]: This study used data from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry and included patients 18 years and older with electrographically confirmed AF. Patients with identified reversible causes of AF or life expectancy less than 6 months were excluded. Data on comorbidity and adverse clinical outcomes were obtained at baseline, and then every 6-months up to 2 years. The primary outcome includes a composite of cardiovascular death, myocardial infarction, stroke/non CNS systemic embolism, or transient ischemic attack. Cluster analysis was performed using 60 baseline variables and resulted in the 4-cluster model as described before. External validation was performed using a mutually excluded ORBIT-AF II Registry.

In analysis of treatment patters, patients in the device implantation cluster were more likely to be managed with rate control. Patients in the low comorbidity cluster were more likely to be on a Class 1c antiarrhythmic agent. Compared to the low-comorbidity cluster, the primary outcome was more common in the behavioural (hazard ratio [HR], 1.49; 95%CI, 1.10-2.00), device implantation (HR, 1.39; 95%CI, 1.15-1.68), and atherosclerotic clusters (HR, 1.59; 95%CI, 1.31-1.92). Major bleeding was more common in the behavioural (HR, 1.35; 95%CI, 1.05-1.73), and device implantation clusters (HR, 1.24; 95%CI, 1.05-1.47).

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: anti-arrhythmicatrial fibrillationtachyarrhythmias
Previous Post

Nonmedical prescription drug use associated with dating violence in adolescents

Next Post

Providing unlimited, immediate access to opioid agonist therapy to people with opioid use disorders could save billions and improve outcomes

RelatedReports

Stroke expansion following intra-arterial therapy may explain worse outcomes
Cardiology

Reduced bleeding risk with asundexian compared to apixaban in patients with atrial fibrillation

April 19, 2022
Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial
Cardiology

Rivaroxaban associated with significantly increased risk of major ischemic or hemorrhagic events versus apixaban in patients with atrial fibrillation

December 22, 2021
#VisualAbstract: Pericardiotomy after cardiac surgery may reduce the incidence of postoperative atrial fibrillation
StudyGraphics

#VisualAbstract: Pericardiotomy after cardiac surgery may reduce the incidence of postoperative atrial fibrillation

December 22, 2021
Resident involvement may not increase postoperative complications in neurosurgery
Cardiology

Pericardiotomy after cardiac surgery may reduce the incidence of postoperative atrial fibrillation

December 14, 2021
Next Post
Participation in sports and exercise linked to lower opioid use

Providing unlimited, immediate access to opioid agonist therapy to people with opioid use disorders could save billions and improve outcomes

Gardasil vaccine demonstrates immunogenic response at 10-year follow-up

Gardasil vaccine demonstrates immunogenic response at 10-year follow-up

Development of a risk index for colorectal cancer screening

Study suggests testing certain protein combinations can enhance sensitivity of fecal immunochemical test used in colorectal cancer screenings

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis
  • Medical cannabis provides little improvement to sleep in chronic pain patients
  • Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.